Predictgad is a patent-pending, AI-driven glaucoma screening solution that detects subtle angle dysgenesis, an early digital marker of glaucoma, using AS-OCT images. By enabling early diagnosis and guiding surgery-first clinical decisions, Predictgad helps prevent irreversible vision loss through the affordable, portable, and scalable deployment of its technology beyond specialist settings.
Patent-pending AI technology
1) Selected for the International Mentorship Program "Scaling Responsible AI Solutions" under the Global Partnership on Artificial Intelligence (GPAI) Initiative. 2) Awarded the 'Young Scientist Award in Health Sciences' at NBRCOM-2024, organized by the Society of Young Biomedical Scientists. 3) Peer-reviewed publications.
A multidisciplinary team of clinicians, AI researchers, and device engineers from premier clinical (AIIMS, New Delhi), intergovernmental research (ICGEB), and private institution (Medevplus), experienced in translational AI, glaucoma research, and scalable healthcare innovation.
